NATERA INC (Common Stock) – ticker 45E (NTRA)
Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Natera (NTRA) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Natera (NTRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks
One investment is a fast-growing genetic testing company that's now generating cash flow and has a scalable business model. The leading semiconductor foundry's sales are booming on AI-led demand, but expanding cash-flow margins will be a challenge.
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
NTRA submits FDA PMA for Signatera CDx, aiming to guide bladder cancer treatment with MRD testing after positive phase 3 trial results.
Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
NTRA & NVDA Partner to Improve AI Models for Precision Medicine
Natera teams up with NVIDIA to train multimodal AI models, aiming to improve precision care through faster, scalable analysis of complex medical data.
Natera, Inc. (NTRA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
Natera, Inc. ( NTRA ) 7th Annual Wolfe Research Healthcare Conference November 19, 2025 10:00 AM EST Company Participants Mike Brophy - Chief Financial Officer Conference Call Participants Douglas Schenkel - Wolfe Research, LLC Presentation Douglas Schenkel Wolfe Research, LLC All right. So last run of the day.
Natera, Inc. (NTRA) Presents at Jefferies London Healthcare Conference 2025 Transcript
Natera, Inc. ( NTRA ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Steve Chapman - CEO & Director Mike Brophy - Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division So I am going to go ahead and kick it off. I'm Tycho Peterson from the Jefferies Life Science team.
Natera, Inc. (NTRA) Q3 2025 Earnings Call Transcript
Natera, Inc. ( NTRA ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Mike Brophy - Chief Financial Officer Steve Chapman - CEO & Director Solomon Moshkevich - President of Clinical Diagnostics Alexey Aleshin - GM of Oncology and ECD & Chief Medical Officer Conference Call Participants Noah Kava - Jefferies LLC, Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Brennan - TD Cowen, Research Division Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Puneet Souda - Leerink Partners LLC, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Presentation Operator Welcome to Natera's 2025 Third Quarter Financial Results Conference Call.
Here's What Key Metrics Tell Us About Natera (NTRA) Q3 Earnings
While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
Natera (NTRA) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.26 per share a year ago.
Natera, Inc. (NTRA) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript
Natera, Inc. (NASDAQ:NTRA ) Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 10:30 AM EDT Company Participants Mike Brophy - Chief Financial Officer Conference Call Participants Eve Burstein - Sanford C. Bernstein & Co., LLC.
